Table 3 Baseline characteristics
From: Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
Overall (N = 955) | buprenorphine (N = 350) | methadone (N = 336) | levomethadone (N = 269) | p-value | |
|---|---|---|---|---|---|
Mean Age (SD) | 33.89 (8.3) | 33.56 (8.5) | 34.14 (8.2) | 34.01 (9.1) | 0.4681 |
Male (%) | 681 (71.3) | 258 (73.7) | 243 (72.3) | 180 (66.9) | 0.1575 |
Depression | 402 (42.1) | 156 (44.6) | 129 (38.4) | 117 (43.5) | 0.2247 |
Personality Disorder | 143 (15.0) | 39 (11.1) | 54 (16.1) | 50 (18.5) | 0.0285 |
Anxiety | 80 (8.4) | 30 (8.6) | 26 (7.7) | 24 (8.9) | 0.8607 |
Sleeping Disorder | 118 (12.4) | 47 (13.4) | 25 (7.4) | 46 (17.1) | 0.0011 |
Chronic Hepatitis C | 365 (38.2) | 126 (36.0) | 124 (36.9) | 114 (42.4) | 0.2292 |
COPD | 63 (6.6) | 20 (5.7) | 29 (8.6) | 14 (5.2) | 0.1699 |
HIV/AIDS | 19 (2.0) | 3 (0.9) | 11 (3.0) | 5 (1.9) | 0.0755 |
Cardiovascular Diseases | 191 (20.0) | 66 (18.9) | 67 (19.9) | 58 (21.56) | 0.706 |
Alcohol Use Disorder | 143 (14.9) | 49 (14.0) | 40 (11.9) | 54 (20.1) | 0.0162 |